New insights on Parkinson's disease, blood vessel growth and cerebral malaria;

> A team at the University of Cambridge ID'd a critical threshold in the levels of a protein called alpha-synuclein, which "normally plays an important role in the smooth flow of chemical signals in the brain." Once the threshold is exceeded, they add, the proteins create a potentially toxic structure that could be a precursor to Parkinson's disease. Release

> Dr. Pipsa Saharinen, at the University of Helsinki, said: "What we have found in our studies on cells and in mice, is another angiopoietin-2 mediated cell pathway, which usually works to destabilize blood vessels, but which also could promote blood vessel growth. This pathway is not necessarily targeted by current angiopoietin-blocking therapies, and this could help explain why some of the trials have not produced as much benefit as we might have hoped." Release

> Researchers at the Harvard T. H. Chan School of Public Health say that an existing drug could be an effective therapy for cerebral malaria. Release

Suggested Articles

Astellas’ Xospata and Novartis’ Rydapt may help treat lung cancer that has grown resistant to EGFR inhibitors, researchers discovered.

Dutch scientists used stem cells from CF patients to demonstrate a technique that corrects a mutation in the gene CFTR without having to cut DNA.

A new map of the thymus gland could help researchers understand how T cells develop and inspire treatments for cancer and autoimmune disease.